Seasonal Allergic Rhinitis Therapeutics
1. Alvesco patent expiration
Treatment: Method of treating inflammatory conditions; Maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. patent claims method for treating a resp...
ALVESCO's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5775321 | COVIS | Seal configuration for aerosol canister |
Jul, 2015
(10 years ago) | |
| US5683677 | COVIS | Medicinal aerosol formulations |
Nov, 2014
(11 years ago) | |
| US5605674 | COVIS | Medicinal aerosol formulations |
Feb, 2014
(11 years ago) | |
| US6036942 | COVIS | Seal configuration for aerosol canister |
Apr, 2013
(12 years ago) | |
| US5482934 | COVIS | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
Oct, 2017
(8 years ago) | |
| US6264923 | COVIS | Medicinal aerosol formulation of ciclesonide and related compounds |
May, 2018
(7 years ago) | |
| US6006745 | COVIS | Device for delivering an aerosol |
Dec, 2016
(9 years ago) | |
| US6120752 | COVIS | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
May, 2018
(7 years ago) | |
| US8371292 | COVIS | Use of ciclesonide for the treatment of respiratory diseases |
Feb, 2028
(1 year, 11 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Oct 20, 2011 |
| M(M-125) | Dec 17, 2015 |
Drugs and Companies using CICLESONIDE ingredient
NCE-1 date: 20 October, 2010
Market Authorisation Date: 10 January, 2008
Dosage: AEROSOL, METERED
More Information on Dosage
ALVESCO family patents
2. Clarinex patent expiration
Treatment: Treatment of chronic idiopathic urticaria; Treatment of allergic rhinitis; A method of treating nasal and non-nasal symptoms of seasonal allergic r...
CLARINEX IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6100274 (Pediatric) | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jan, 2020
(6 years ago) | |
|
US7214684 (Pediatric) | ORGANON | Methods for the treatment of allergic rhinitis |
Jun, 2015
(10 years ago) | |
|
US5607697 (Pediatric) | ORGANON | Taste masking microparticles for oral dosage forms |
Dec, 2015
(10 years ago) | |
| US6514520 | ORGANON | Stabilized antihistamine syrup |
Jun, 2018
(7 years ago) | |
| US7211582 | ORGANON | Methods for treating urticaria using descarboethoxyloratadine |
Dec, 2014
(11 years ago) | |
| US7214684 | ORGANON | Methods for the treatment of allergic rhinitis |
Dec, 2014
(11 years ago) | |
| US7214683 | ORGANON | Compositions of descarboethoxyloratadine |
Dec, 2014
(11 years ago) | |
| US7618649 | ORGANON | Extended release oral dosage composition |
Dec, 2020
(5 years ago) | |
| US5607697 | ORGANON | Taste masking microparticles for oral dosage forms |
Jun, 2015
(10 years ago) | |
| US6100274 | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jul, 2019
(6 years ago) | |
|
US7214683 (Pediatric) | ORGANON | Compositions of descarboethoxyloratadine |
Jun, 2015
(10 years ago) | |
|
US7211582 (Pediatric) | ORGANON | Methods for treating urticaria using descarboethoxyloratadine |
Jun, 2015
(10 years ago) | |
|
US7618649 (Pediatric) | ORGANON | Extended release oral dosage composition |
Jun, 2021
(4 years ago) | |
|
US7405223 (Pediatric) | ORGANON | Treating allergic and inflammatory conditions |
Jan, 2020
(6 years ago) | |
|
US6514520 (Pediatric) | ORGANON | Stabilized antihistamine syrup |
Dec, 2018
(7 years ago) | |
| US7405223 | ORGANON | Treating allergic and inflammatory conditions |
Jul, 2019
(6 years ago) | |
Drugs and Companies using DESLORATADINE ingredient
Market Authorisation Date: 14 July, 2005
Dosage: TABLET, ORALLY DISINTEGRATING; TABLET; SOLUTION
How can I launch a generic of CLARINEX before it's drug patent expiration?
More Information on Dosage
CLARINEX family patents